Counsel William A. Garvin Presents at Specialty Pharma Association’s 2014 Annual Pharma Conference
Buchanan Ingersoll & Rooney Counsel William A. Garvin presented at the Specialty Pharma Association’s 2014 Annual Pharma Conference held in Orlando from April 1-3. In his April 1 presentation, Garvin discussed “Medical Foods,” and their gaining interest among Specialty Pharma companies as new products constantly enter the market place. He explained the definitions of different medical food products and the related regulatory issues behind them.
On April 3, Garvin presented a “Regulatory Updated.” In his presentation, he spoke about current issues and actions from the FDA, the DEA and certain State Boards of Pharmacy that directly affect companies active within the Specialty Pharma industry.
On April 3, Garvin presented a “Regulatory Updated.” In his presentation, he spoke about current issues and actions from the FDA, the DEA and certain State Boards of Pharmacy that directly affect companies active within the Specialty Pharma industry.
Contributors
Related Services & Industries
- AFFORDABLE HOUSING
- ANTITRUST & TRADE REGULATION
- APPELLATE
- ATTORNEY UPDATE
- AUTONOMOUS & CONNECTED VEHICLES
- BANKRUPTCY & CREDITORS' RIGHTS
- BUCHANAN IP GUEST ASSOCIATE PROGRAM
- CANNABIS
- CLASS ACTIONS
- COAL
- COMBINED HEAT & POWER (CHP)
- COMMERCIAL CONTRACTS
- COMMERCIAL FINANCE
- CONSTRUCTION
- CONSUMER DEFENSE
- CONSUMER PRODUCTS
- CONTACT INFORMATION
- CONVERGENCE: M&A INSIGHTS IN HEALTHCARE
- COPYRIGHT
- CORONAVIRUS (COVID-19)
- CORPORATE
- CORPORATE COMPLIANCE
- CORPORATE TAX
- CRIMINAL DEFENSE & GOVERNMENT ENFORCEMENT
- CYBERSECURITY & DATA PRIVACY
- E-DISCOVERY
- EDUCATION
- EMERGING COMPANIES
- EMPLOYEE BENEFITS & ERISA
- EMPLOYMENT LITIGATION
- ENERGY
- ENTERTAINMENT, MEDIA & SPORTS
- ENVIRONMENTAL
- ESTATES & TRUSTS
- EXECUTIVE COMPENSATION
- FAMILY OFFICE
- FDA & BIOTECHNOLOGY
- FINANCE
- FRANCHISE & DISTRIBUTION
- GOVERNMENT RELATIONS & PUBLIC POLICY
- HEALTHCARE
- HEALTHCARE ADMINISTRATIVE & JUDICIAL PROCEEDINGS
- HEALTHCARE INFORMATION SECURITY & PRIVACY
- HEALTHCARE LITIGATION
- HEALTHCARE REGULATORY & COMPLIANCE
- HEALTHCARE TRANSACTIONS
- HOSPITALITY
- HR & EMPLOYEE RELATIONS ISSUES
- IMMIGRATION
- INNOVATIVE HEALTHCARE DELIVERY & PAYMENT
- INSIDER INSIGHTS:
100 DAYS OF BIDEN - INSURANCE & REINSURANCE
- INTELLECTUAL PROPERTY
- INTERNAL INVESTIGATIONS
- INTERNATIONAL SERVICES
- INTERNATIONAL TAX
- IP LITIGATION
- LABOR & EMPLOYMENT
- LIFE SCIENCES
- LITIGATION
- MANUFACTURING
- MARITIME & ADMIRALTY
- MATRIMONIAL & FAMILY LAW
- MERGERS & ACQUISITIONS
- NONPROFIT ORGANIZATIONS
- OIL & GAS
- OPPORTUNITY ZONES
- PASS-THROUGH ENTITIES
- PATENT COUNSELING & STRATEGIC ADVICE
- PATENT OFFICE LITIGATION
- PATENT PROCUREMENT
- POST-ACUTE & LONG-TERM CARE
- POWER GENERATION & UTILITY
- PRODUCTS LIABILITY
- PUBLIC FINANCE
- PUBLIC PROCUREMENT & BID PROTESTS
- REAL ESTATE
- REAL ESTATE FINANCE
- REAL ESTATE TRANSACTIONS
- REIMBURSEMENT & MANAGED CARE
- RENEWABLES
- SECURITIES & SEC
- SECURITY ALARM
- SPORTS
- STATE & LOCAL TAX
- TAX
- TAX CONTROVERSY
- TECHNOLOGY TRANSACTIONS
- TRADE SECRETS & RESTRICTIVE COVENANTS
- TRADEMARK
- TRADITIONAL LABOR RELATIONS
- TRANSPORTATION
- VENTURE CAPITAL & PRIVATE EQUITY
- WATER
- WEALTH & SUCCESSION PLANNING
- WHITE COLLAR DEFENSE, COMPLIANCE & INVESTIGATIONS
- WORKPLACE SAFETY & HEALTH (OSHA & MSHA)
Related Offices